(Q37752381)

22 August 2017

1 reference

title

Glioma stem cell signaling: therapeutic opportunities and challenges (English)

1 reference

22 August 2017

Jörg Dietrich

1

1 reference

22 August 2017

Eli L Diamond

series ordinal

2

1 reference

22 August 2017

Santosh Kesari

series ordinal

3

1 reference

22 August 2017

publication date

1 May 2010

1 reference

Expert Review of Anticancer Therapy

22 August 2017

published in

1 reference

22 August 2017

volume

10

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

709-722

1 reference

Identification of human brain tumour initiating cells

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Characterization of clonogenic multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Prostate cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Cancerous stem cells can arise from pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Intersections between neurobiology and oncology: tumor origin, treatment and repair of treatment-associated damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Mechanisms of Disease: the role of stem cells in the biology and treatment of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Cancer stem cells in radiation resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Emerging antiangiogenic treatments for gliomas - efficacy and safety issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Vascular niche for adult hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Neuroscience. Cellular interactions in the stem cell niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

For the long run: maintaining germinal niches in the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Molecular regulation of adult CNS neurogenesis: an integrated view

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

A perivascular niche for brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Neural stem cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Angiogenesis as a therapeutic target in malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

The bad seed: PDGF receptors link adult neural progenitors to glioma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Growth factor profiles of human gliomas. Do non-tumour cells contribute to tumour growth in glioma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Mechanisms of disease: the PI3K-Akt-PTEN signaling node--an intercept point for the control of angiogenesis in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

PTEN mutations in gliomas and glioneuronal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

The biology and clinical relevance of the PTEN tumor suppressor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Malignant astrocytic glioma: genetics, biology, and paths to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Structural alterations of the epidermal growth factor receptor gene in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Epidermal growth factor receptor and Ink4a/Arf

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Phase II trial of gefitinib in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Effects of the VEGFR inhibitor ZD6474 in combination with radiotherapy and temozolomide in an orthotopic glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Developmental expression of the platelet-derived growth factor alpha-receptor gene in mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Platelet-derived growth factor in human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Altered molecular pathways in gliomas: an overview of clinically relevant issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Microvessel density is a prognostic indicator for patients with astroglial brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Cellular composition and cytoarchitecture of the adult human subventricular zone: a niche of neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Making a tumour's bed: glioblastoma stem cells and the vascular niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Expression of hypoxia-inducible factor 1? in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Angiogenesis in malignant glioma--a target for antitumor therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Brain cancer stem cells display preferential sensitivity to Akt inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

The role of Notch in tumorigenesis: oncogene or tumour suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

The many facets of Notch ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Notch, neural stem cells, and brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Signalling downstream of activated mammalian Notch

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Notch1 and its ligands Delta-like and Jagged are expressed and active in distinct cell populations in the postnatal mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

The role of notch in promoting glial and neural stem cell fates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Primitive neural stem cells from the mammalian epiblast differentiate to definitive neural stem cells under the control of Notch signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Notch signaling in the mammalian central nervous system: insights from mouse mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Notch signalling regulates stem cell numbers in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Radial glial identity is promoted by Notch1 signaling in the murine forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Notch1 and Notch3 instructively restrict bFGF-responsive multipotent neural progenitor cells to an astroglial fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Notch1 is essential for postimplantation development in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Notch1 and notch2 have opposite effects on embryonal brain tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Notch signaling enhances nestin expression in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Contribution of Notch signaling activation to human glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Notch emerges as new cancer drug target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Drosophila perlecan modulates FGF and hedgehog signals to activate neural stem cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Sonic hedgehog controls stem cell behavior in the postnatal and adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Hedgehog serves as a mitogen and survival factor during embryonic stem cell neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Hedgehog signaling and primary cilia are required for the formation of adult neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Hedgehog signaling is involved in development of the neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Altered neural cell fates and medulloblastoma in mouse patched mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Medulloblastoma growth inhibition by hedgehog pathway blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Hedgehog signalling in cancer formation and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Gli and hedgehog in cancer: tumours, embryos and stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Signal Transduction and the Control of Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

WNT and beta-catenin signalling: diseases and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Wnt signalling in stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Wnt signalling required for expansion of neural crest and CNS progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Regulation of cerebral cortical size by control of cell cycle exit in neural precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

beta-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Endogenous Wnt signaling maintains neural progenitor cell potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Wnt signalling regulates adult hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Beta-catenin-mediated Wnt signaling regulates neurogenesis in the ventral telencephalon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Role of Wnt pathway in medulloblastoma oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Medulloblastoma: developmental mechanisms out of control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Upregulation of frizzled 9 in astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

PTEN in neural precursor cells: regulation of migration, apoptosis, and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Tumour-suppressor function in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

PTEN signaling pathways in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Stem cells and cancer; the polycomb connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Bmi1 and cell of origin determinants of brain tumor phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Emerging functions of microRNAs in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Oncogenic role of microRNAs in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

MicroRNA regulation of cancer stem cells and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

MicroRNA silencing in primates: towards development of novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Irradiation induces neural precursor-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor ceil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.09.190

21 January 2018

Identifiers

DOI

10.1586/ERA.09.190

1 reference

22 August 2017

1 reference